Correlation Between Acumen Pharmaceuticals and Collegium Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and Collegium Pharmaceutical, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Collegium Pharmaceutical.

Diversification Opportunities for Acumen Pharmaceuticals and Collegium Pharmaceutical

0.07

Correlation Coefficient

Acumen Pharmaceuticals  Collegium Pharmaceutical

Significant diversification

The 3 months correlation between Acumen and Collegium is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Collegium Pharmaceutical go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Collegium Pharmaceutical

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 1.89 times more return on investment than Collegium Pharmaceutical. However, Acumen Pharmaceuticals is 1.89 times more volatile than Collegium Pharmaceutical. It trades about -0.02 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.11 per unit of risk. If you would invest  245.00  in Acumen Pharmaceuticals on September 12, 2024 and sell it today you would lose (28.00) from holding Acumen Pharmaceuticals or give up 11.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  Collegium Pharmaceutical

Acumen Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Collegium Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Acumen Pharmaceuticals and Collegium Pharmaceutical

The main advantage of trading using opposite Acumen Pharmaceuticals and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.

The idea behind Acumen Pharmaceuticals and Collegium Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.